Literature DB >> 19933673

Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle.

Richard L Ellis1.   

Abstract

OBJECTIVE: The objective of this article is to describe a method for timing breast MRI examinations corresponding to the follicular phase of the menstrual cycle in premenopausal women without cyclical menses, thereby reducing the number of false-positive findings and nondiagnostic examinations.
CONCLUSION: Serum progesterone concentrations corresponding to the follicular phase of a normal menstrual cycle can aid in optimal scheduling of breast MRI examinations for premenopausal women who lack cyclical menses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933673     DOI: 10.2214/AJR.09.2657

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Quantification of background enhancement in breast magnetic resonance imaging.

Authors:  C Klifa; S Suzuki; S Aliu; L Singer; L Wilmes; D Newitt; B Joe; N Hylton
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

2.  High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.

Authors:  Chuanhui Xu; Jinhui Yu; Feifei Wu; Xuemei Li; Dongmin Hu; Guiming Chen; Gang Wu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?

Authors:  Jana Taron; Sabrina Fleischer; Heike Preibsch; Konstantin Nikolaou; Ines Gruber; Sonja Bahrs
Journal:  Eur Radiol       Date:  2018-09-18       Impact factor: 5.315

Review 4.  Breast MRI: EUSOBI recommendations for women's information.

Authors:  Ritse M Mann; Corinne Balleyguier; Pascal A Baltzer; Ulrich Bick; Catherine Colin; Eleanor Cornford; Andrew Evans; Eva Fallenberg; Gabor Forrai; Michael H Fuchsjäger; Fiona J Gilbert; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Julia Camps-Herrero; Christiane K Kuhl; Laura Martincich; Federica Pediconi; Pietro Panizza; Luis J Pina; Ruud M Pijnappel; Katja Pinker-Domenig; Per Skaane; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

5.  Comparison between breast MRI and contrast-enhanced spectral mammography.

Authors:  Elżbieta Łuczyńska; Sylwia Heinze-Paluchowska; Edward Hendrick; Sonia Dyczek; Janusz Ryś; Krzysztof Herman; Paweł Blecharz; Jerzy Jakubowicz
Journal:  Med Sci Monit       Date:  2015-05-12

6.  The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.

Authors:  Suzan Vreemann; Albert Gubern-Mérida; Cristina Borelli; Peter Bult; Nico Karssemeijer; Ritse M Mann
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

7.  Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients.

Authors:  Chao You; Weijun Peng; Wenxiang Zhi; Min He; Guangyu Liu; Li Xie; Luan Jiang; Xiaoxin Hu; Xuxia Shen; Yajia Gu
Journal:  Transl Oncol       Date:  2017-08-12       Impact factor: 4.243

Review 8.  Abbreviated Magnetic Resonance Imaging for Breast Cancer Screening: Concept, Early Results, and Considerations.

Authors:  Eun Sook Ko; Elizabeth A Morris
Journal:  Korean J Radiol       Date:  2019-04       Impact factor: 3.500

9.  Current and Future Directions of Breast MRI.

Authors:  Margaret Houser; David Barreto; Anita Mehta; Rachel F Brem
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.